Google
Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
Marina Ramirez-Alvarado, PhD
Researcher Professor
Mayo Clinic
200 First St. SW
Rochester, Minnesota, United States
Marina Ramirez-Alvarado is a Professor of Biochemistry and Molecular Biology at the Mayo Clinic, Rochester, Minnesota. She studies misfolding and amyloid formation in light chain amyloidosis. The overall goal of her research laboratory is to understand the molecular basis of this disease to ultimately find ways to ameliorate the organ damage it causes and eventually find new therapeutic strategies to improve organ function and quality of life for patients and increase overall survival.
Dr. Ramirez-Alvarado’s current projects aim at understanding the structural basis for toxicity in light chain amyloidosis. It is now accepted that soluble species populated in the initial steps of amyloid formation are quite toxic and can cause severe organ damage. Dr. Ramirez-Alvarado is utilizing her well-characterized protein systems with incredible biophysical knowledge to determine which species are causing the devastating damage observed in AL amyloidosis.
Dr. Ramirez-Alvarado works very closely with clinical investigators in the Division of Hematology, the Division of Nephrology and Hypertension, and the Division of Cardiovascular Diseases.
Representative Publications:
myBinderRelated Content
-
Managing AL Treatment Side Effects by Dr. Morie Gertz – ASG Webinar – 1/9https://www.youtube.com/watch?v=vP4wvJq5...
-
Stem Cell Transplant or Dara-CyBorD – ASG Webinar 12/13https://www.youtube.com/watch?v=4gUXPbOk...
-
Q&A With Drs. Leung and Urey – ASG Webinar – 6/9https://www.youtube.com/watch?v=vP4wvJq5...
-
Right Ventricular Longitudinal Strain: A Tool for Diagnosis and Prognosis in Light-Chain AmyloidosisObjectives: Light-chain (AL) amyloidosi...
-
Fibril Antibodies and Caelum CAEL-101 Trial – ASG Webinar 9/13https://www.youtube.com/watch?v=4gUXPbOk...
-
Light-Chain Cardiac AmyloidosisCardiac amyloidosis is an underrecognize...
-
Clarification on the Definition of Complete Haematologic Response in Light-Chain (AL) AmyloidosisThe International Society of Amyloidosis...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
